Position in LQDA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$6,139
New position
Shares Held
77
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#309
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026C M BIDWELL & ASSOCIATES LTD holds $588,931 across 7 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
1,369 | $230,731 | |
| 2 | ALKS |
Alkermes plc.
|
1,981 | $103,804 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
5,415 | $93,733 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,895 | $77,751 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
916 | $75,826 | |
| 6 | LQDA |
Liquidia Corp
This page
|
77 | $6,139 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
225 | $947 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,139 | 77 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||